Pfizer COVID-19 tablet approved for home use by US | Coronavirus Plague News
Numerous studies show that oral contraceptives are 90 percent effective in preventing death and hospitalization for high-risk patients.
Health authorities in the United States have approved first oral contraceptives against COVID-19, a Pfizer product which users can take home to eliminate the harmful effects of coronavirus.
The long-awaited event was announced Wednesday by the US Food and Drug Administration (FDA). The approval comes at a time when the number of coronavirus cases is increasing worldwide, including in the US, with health officials warning of a new tsunami from Omicron range which could hamper hospitals.
Data from Pfizer’s clinical trials showed that its antiviral drugs were 90 percent effective. hospitalization and death among patients at high risk for hypertension. Recent laboratory data suggest that the drug remains effective against Omicron.
The drug, Paxlovid, is a quick, inexpensive way to treat the first infection of COVID-19, although the basics will be very limited. All previously prescribed anti-inflammatory drugs require an IV or injection.
“Efficiency is plentiful, the results are minimal and it is just verbal. It looks at all the boxes,” says Dr Gregory Poland of the Mayo Clinic from the US. “Looking at the fact that 90 percent reduced the risk of hospitalization and death in the high-risk group – it’s amazing.”
The FDA said it has approved the drug for emergency use in the treatment of mild to moderate infections in adults and children. patients 12 years of age and older people weighing about 40kg (88 pounds), who are at high risk of developing COVID-19. This includes the elderly and those with conditions such as obesity and heart disease.
“This license provides a new tool to deal with COVID-19 at a critical time in the epidemic new ones are coming out and promises to make antiretroviral treatment available to patients at high risk of COVID-19, “said Patrizia Cavazzoni, director of FDA’s Center for Drug Evaluation and Research, in a statement.
The drug is only available with the drug and should be prescribed as soon as possible after being diagnosed with COVID-19 and within five days of the onset of symptoms, the agency said.
Pfizer is part of a family of decades of antiretroviral drugs known as protease inhibitors, which completely transform the treatment of HIV and hepatitis C. These drugs protect the vital protein that viruses need to multiply in the human body. .
The company said it was ready to launch live births in the US and increase its production estimates to 120 million drugs from 80 million by 2022.
A U.S. government contract for 10 million Pfizer drug courses costs $ 530 for these studies.
Pfizer pill comes with its own side effects.
Patients will need to be tested for COVID-19 in order to receive the drug. And Paxlovid has proven to be effective if given within five days of the symptoms showing. Once the test material is stretched, experts worry that it may not be possible for patients to test themselves, get tested, see a doctor and take medication inside a narrow window.
“When you go out at that time I hope the drug will diminish,” said Andrew Pekosz, a virologist at Johns Hopkins University.
A pill against Merck & Co, which is being reviewed by the FDA, has shown less potency compared to Pfizer products. Merck’s drug, molnupiravir, reduced hospital mortality and mortality in its clinical trials for high-risk patients by about 30 percent.
Pfizer and Merck tablets are expected to be effective against Omicron because they do not look for a spike protein where there are dangerous mutations of this type.
Many health experts say the vaccine is still the best way to protect yourself from COVID-19. But with nearly 40 million American adults still uncircumcised, effective treatment will be needed to eradicate existing and future diseases.
